Clinical Trial Update: Study to Assess Safety,Tolerability,Efficacy of PM01183 and Atezolizumab in Patients w/ Advanced Small Cell Lung Cancer. [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial evaluating the safety, tolerability, and efficacy of PM01183 combined with atezolizumab in advanced small cell lung cancer is ongoing (Phase 1/…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• Atezolizumab (atezolizumab)
• PM01183 (PM01183)

Snippet

Sponsor: Fundacion Oncosur | Conditions: Carcinoma, Small Cell Lung | Phase 1, Phase 2 | Status: UNKNOWN